| Literature DB >> 35324685 |
Ana Guimarães1,2, Armando Venâncio1,2.
Abstract
Fungal contamination presents several problems: in humans, health issues arise from infections with opportunistic filamentous fungi and yeast, while in food, fungi cause spoilage and, in particular, in the case of mycotoxigenic fungi, can cause serious health issues. Several types of fatty acids and their derivatives, oxylipins, have been found to have inhibitory effect towards fungal growth and the production of mycotoxins. The use of fatty acids as antifungals could fulfil consumer's requests of more natural and environmentally friendly compounds, while being less likely to promote fungal resistance. In addition, due to their nature, fatty acids are easily used as food additives. In this work, we review the most relevant and recent studies on the antifungal ability of fatty acids. We focused on saturated fatty acids, unsaturated fatty acids, and oxylipins, their different impact on fungal inhibition, their proposed modes of action, and their ability to impair mycotoxin production. Applications of fatty acids as antifungals and their limitations are also addressed.Entities:
Keywords: fungal contamination; hydroxy fatty acid; mycotoxins; oxylipins; saturated fatty acids; unsaturated fatty acids
Mesh:
Substances:
Year: 2022 PMID: 35324685 PMCID: PMC8954725 DOI: 10.3390/toxins14030188
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1Chemical structure of fatty acids and derivatives: (A) saturated fatty acids (stearic acid); (B) cis monounsaturated fatty acid (cis oleic acid); (C)trans monounsaturated fatty acid (trans oleic acid); (D) polyunsaturated fatty acid (linoleic acid); (E) hydroxy fatty acid (ricinoleic acid); (F) fatty acid methyl ester (stearic acid methyl ester).
Figure 2Antifungal mechanisms of fatty acids. FA: fatty acid; TI: topoisomerase I; ER: endoplasmic reticulum; R: ribosome. Adapted from Pohl et al. [14].
Figure 3Oxidative metabolism of PUFA C18 fatty acids in plants. FA: fatty acid; LOX: lipoxygenase; α-DOX: α-dioxygenase; AOC: allene oxide cyclase; AOS: allene oxide synthase; DES: divinyl ether synthase; EAS: epoxy alcohol synthase; HPL: hydroperoxide lyase. Adapted from Deboever et al. (2020) [69].
Hydroxy fatty acids with antifungal activity and their MIC against target fungi.
| Hydroxy Fatty Acids | Target Fungi | MIC | Reference |
|---|---|---|---|
| 2-hydroxydecanoic acid; 3-( | MIC of 10 to100 μg/mL for the racemic forms of the 3-OH fatty acids | Sjögren et al. (2003) [ | |
| 3-hydroxydecanoic acid | MIC 100 μg/mL | Broberg et al. (2007) [ | |
| 9-HODE; 13-HODE; DOD; 9,10,13-TriHOME(11) and 9,12,13-TriHOME(10) | MIC of mono-, di-, and trihydroxy fatty acids produced by | Martin-Arjol et al. (2010) [ | |
| coriolic and ricinoleic acid | MICs of 100 to 700 μg/mL for coriolic acid and 2400 μg/mL for ricinoleic acid | Black et al. (2013) [ | |
| 13-HOE, 10-HOE, coriolic acid, ricinoleic acid | MIC of 250 to 420 μg/mL against | Chen et al. (2016) [ | |
| Coriolic acid, ricinoleic acid, 10-HOE, 13-HOE | For coriolic acid, MIC of 70 to 670 μg/mL against filamentous fungi and of 4000 to ≥8000 μg/mL against yeasts. For mono hydroxy acids MIC from 290 to 500 μg/mL against | Liang et al. (2017) [ | |
| 3-hydroxy-5-dodecenoic acid |
| MIC of 3-hydroxy-5-dodecenoic acid against | Mun et al. (2019) [ |
| coriolic acid; dimorphecolic acid, ricinoleic acid, 10-OH C18:1, kamlolenic acid, 2-hydroxy linolenic acid, 2-hydroxy oleic acid | MIC from 230 to 1500 μg/mL against | Liang et al. (2020) [ |
9-HODE: 9-hydroxy-10,12-octadecadienoic acid; 13-HODE: 13-hydroxy-9,11-octadecadienoic acid; DOD -7,10-dihydroxy-8E-octadecenoic acid; 9,10,13-THOE(11): 9,10,13-trihydroxy-11-octadecenoic acid; 9,12,13-THOE(10): 9,12,13-trihydroxy-10-octadecenoic acid; coriolic acid: 13-hydroxy-9,11-octadecadienoic acid; ricinoleic acid: 12-hydroxy-9-octadecenoic; 13-HOE: 13-hydroxy-9-octadecenoic acid; 10-HOE: 10-hydroxy-12-octadecenoic acid; dimorphecolic acid: 9-hydroxy-10,12-octadecadienoic acid; kamlolenic acid: 18-hydroxy-9E,11E,13E-octadecatrienoic acid.
Fatty acids and derivatives with activity in mycotoxin production.
| Fatty Acids and Derivatives | Target Fungi | Mycotoxin | Mycotoxin Production Variation | Concentrations Tested | Reference |
|---|---|---|---|---|---|
| myristic acid |
| Aflatoxin | promoted production of AFL | 5 mM | Priyadarshini et al. (1980) [ |
| palmitic acid | promoted production of AFL | ||||
| stearic acid | promoted production of AFL | ||||
| oleic acid | inhibited production of AFL | ||||
| linoleic acid | inhibited production of AFL | ||||
| linoleic acid peroxide |
| Aflatoxins | increased by at least 5000% | 0.5 mg/mL | Fabbri et al. [ |
| linoleic acid hydroperoxide | increased by at least 3000% | ||||
| lauric acid |
| Aflatoxins | decreased by 10% to 45% | 50 to 300 mM | Tiwari et al. (1986) [ |
| myristic acid | decreased by 14% | 300 mM | |||
| palmitic acid | decreased by 11% to 76% | 10 to 300 mM | |||
| docosanoic acid | increased by 290% to 540% | 10 to 150 mM | |||
| linoleic acid | increased by 3400% | 50 mM | |||
| linolenic acid | increased by 1100% | 10 mM | |||
| linoleic acid hydroperoxides |
| Aflatoxin | promoted production of AFL | non-specified | Hamid and Smith (1987) [ |
| stearic acid | promoted production of AFL | ||||
| linoleic acid | inhibited production of AFL | ||||
| 9S-HPODE |
| Aflatoxins | inhibited by ~30% | 1to 100 μM | Burow et al. (1997) [ |
| 13S-HPODE | inhibited by ~40% | 1 to 100 μM | |||
| 13S-HPOTE | Aflatoxin and NOR | inhibited AFL by 100% and NOR by 90% | 100 μM | ||
| 13S-HPODE |
| ST | inhibited by 52% to 81% | 1 to 100 μM | |
| 9S-HPODE |
| Aflatoxin | increased production | non-specified | Wilson et al. [ |
| methyl jasmonate |
| Aflatoxin | promoted production | 1 mM | Vergopoulou et al. [ |
| 9S-HPODE |
| Aflatoxins | increased production | non-specified | Tsitsigiannis et al. (2005) [ |
| 13S-HPODE | inhibited production | ||||
| methyl jasmonate |
| Aflatoxin | 1 μM promoted AFL production and 10 mM totally inhibited AFL production | 1 μM to 10 mM | Meimaroglou et al. [ |
| 9-HODE |
| DON | promoted production | non-specified | Nobili et al. (2014) [ |
| 9-HPODE | |||||
| stearic acid |
| Aflatoxins | increased production | 0.1, 0.75, and 1.25 mM | Yan et al. (2015) [ |
| linolenic acid | inhibited production | 1.25 and 5 mM | |||
|
| Aflatoxin | inhibited production up to 30% | 25 to 100 μM | Orsoni et al. (2020) [ | |
| JTS | inhibited by 55% to 100% | ||||
| Jdi | inhibited production up to 30% | ||||
| JdiTS | inhibited by 20% to 70% | ||||
| JTS-Cu | inhibited by 45% to 90% | ||||
| JdiTS-Cu | inhibited by 40% to 70% | ||||
|
| HT-2 toxin | no inhibition | 5 to 25 μM | ||
| JTS | inhibited by 40% to 75% | ||||
| Jdi | no inhibition | ||||
| JdiTS | inhibited by 25% to 75% |